Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox protein Hox-D3 (HOXD3) is a sequence-specific transcription factor belonging to the homeobox family, a group of highly conserved developmental regulators involved in morphogenesis across multicellular organisms[1][2][3][7]. HOXD3 is located on human chromosome 2q31-2q37 and is one gene of the HOXD gene cluster[1]. It specifies cellular positional identity during embryogenesis and regulates processes such as cell adhesion and gene expression[1][7]. Deletion of the HOXD gene cluster or its 5′ end is associated with severe limb and genital abnormalities[1]. Dysregulation of HOXD3 is implicated in cancer, including promoting colorectal cancer growth and roles in hepatocellular carcinoma progression[6][8]. No drugs are currently listed as direct interactors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox protein Hox-D3 (HOXD3).